Iconography : Comprehensive morpho-constitutional analysis of urinary stones improves etiological diagnosis and therapeutic strategy of nephrolithiasis
暂无分享,去创建一个
M. Daudon | P. Jungers | A. Dessombz | V. Frochot | E. Letavernier | J. Haymann | D. Bazin
[1] J. Rode,et al. Hyperoxaluria is related to whewellite and hypercalciuria to weddellite: What happens when crystalline conversion occurs? , 2016 .
[2] A. Blanchard,et al. Désordres de la magnésémie , 2015 .
[3] M. Daudon,et al. Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis. , 2015, The Journal of urology.
[4] M. Daudon,et al. Demographics and Characterization of 10,282 Randall Plaque-Related Kidney Stones , 2015, Medicine.
[5] U. Maggiore,et al. Recurrent 2,8‐Dihydroxyadenine Nephropathy: A Rare but Preventable Cause of Renal Allograft Failure , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] B. Canales,et al. Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies. , 2014, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[7] J. Lieske,et al. Sustained Pyridoxine Response in Primary Hyperoxaluria Type 1 Recipients of Kidney Alone Transplant , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] M. Daudon,et al. Therapy modifies cystine kidney stones at the macroscopic scale. Do such alterations exist at the mesoscopic and nanometre scale , 2014 .
[9] M. Daudon. Vitamine D, plaque de Randall et lithiase : existe-t-il un lien ? , 2013 .
[10] F. Grases,et al. Renal papillary calcification and the development of calcium oxalate monohydrate papillary renal calculi: a case series study , 2013, BMC Urology.
[11] J. Groothoff,et al. Primary hyperoxaluria type 1, a too often missed diagnosis and potentially treatable cause of end-stage renal disease in adults: results of the Dutch cohort. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[12] E. Salido,et al. Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] A. Alaya,et al. Changes in Urinary Stone Composition in the Tunisian Population: A Retrospective Study of 1,301 Cases , 2012, Annals of laboratory medicine.
[14] R. Wallace,et al. Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. , 2011, The American journal of clinical nutrition.
[15] M. Daudon,et al. Does urinary stone composition and morphology help for prediction of primary hyperparathyroidism? , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] M. Daudon,et al. Composition and morphology of phosphate stones and their relation with etiology , 2010, Urological Research.
[17] M. Daudon,et al. Decreased kidney function and crystal deposition in the tubules after kidney transplant. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] Seth K Bechis,et al. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. , 2010, The Journal of urology.
[19] M. Daudon,et al. Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency. , 2010, Journal of the American Society of Nephrology : JASN.
[20] L. Dimeglio,et al. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. , 2010, The Journal of clinical endocrinology and metabolism.
[21] M. Econs,et al. Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3/type IIc sodium-phosphate cotransporter: presentation as hypercalciuria and nephrolithiasis. , 2009, The Journal of clinical endocrinology and metabolism.
[22] Alain Mallet,et al. Estimation of urinary stone composition by automated processing of CT images , 2009, Urological Research.
[23] M. Stoller,et al. Hyperoxaluria after modern bariatric surgery: case series and literature review , 2009, International Urology and Nephrology.
[24] M. Daudon,et al. Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology. , 2009, Urology.
[25] A. Evan,et al. Clinical and laboratory characteristics of calcium stone‐formers with and without primary hyperparathyroidism , 2009, BJU international.
[26] M. Daudon,et al. Examination of whewellite kidney stones by scanning electron microscopy and powder neutron diffraction techniques , 2009 .
[27] M. Daudon,et al. [Epidemiology of urolithiasis]. , 2008, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[28] M. Daudon,et al. Peculiar morphology of stones in primary hyperoxaluria. , 2008, The New England journal of medicine.
[29] J. Lingeman,et al. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. , 2008, Kidney international.
[30] T. Strom,et al. PHEX, FGF23, DMP1 and beyond , 2008, Current opinion in nephrology and hypertension.
[31] N. Loh,et al. Genetic causes of hypercalciuric nephrolithiasis , 2008, Pediatric Nephrology.
[32] J. Lingeman,et al. Renal histopathology of stone-forming patients with distal renal tubular acidosis. , 2007, Kidney international.
[33] F. Coe,et al. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. , 2007, The Journal of urology.
[34] M. Daudon,et al. Type 2 diabetes increases the risk for uric acid stones. , 2006, Journal of the American Society of Nephrology : JASN.
[35] M. Daudon,et al. Drug-Induced Renal Calculi , 2006, Drugs.
[36] A. Evan,et al. Kidney stone disease. , 2005, The Journal of clinical investigation.
[37] B. Hoppe,et al. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] M. Daudon,et al. High prevalence of uric acid calculi in diabetic stone formers. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[39] J. Lingeman,et al. Crystal-associated nephropathy in patients with brushite nephrolithiasis. , 2005, Kidney international.
[40] M. Daudon,et al. [Composition of renal stones currently observed in non-industrialized countries]. , 2004, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.
[41] M. Stampfer,et al. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. , 2004, Journal of the American Society of Nephrology.
[42] J. Lingeman,et al. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. , 2004, Kidney international.
[43] H. Moutsopoulos,et al. Clinical manifestations and early diagnosis of Sjögren syndrome. , 2004, Archives of internal medicine.
[44] M. Fulop,et al. Renal tubular acidosis, Sjögren syndrome, and bone disease. , 2004, Archives of internal medicine.
[45] H. Simmonds,et al. Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[46] C. Pak,et al. Biochemical and physicochemical presentations of patients with brushite stones. , 2004, The Journal of urology.
[47] N. Abate,et al. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. , 2004, Kidney international.
[48] R. Paterson,et al. Urine calcium and volume predict coverage of renal papilla by Randall's plaque. , 2003, Kidney international.
[49] Beverley Adams-Huet,et al. Predictive value of kidney stone composition in the detection of metabolic abnormalities. , 2003, The American journal of medicine.
[50] R. Paterson,et al. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. , 2003, The Journal of clinical investigation.
[51] M. Zafar,et al. Management of pediatric urolithiasis in Pakistan: experience with 1,440 children. , 2003, The Journal of urology.
[52] B. Gérard,et al. Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter. , 2002, The New England journal of medicine.
[53] B. Adams-Huet,et al. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. , 2002, Kidney international.
[54] V. Tasic,et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. , 2001, Journal of the American Society of Nephrology : JASN.
[55] A. Sarkissian,et al. Pediatric urolithiasis in Armenia: a study of 198 patients observed from 1991 to 1999 , 2001, Pediatric Nephrology.
[56] W. Frawley,et al. Biochemical profile of idiopathic uric acid nephrolithiasis. , 2001, Kidney international.
[57] R. Manchanda,et al. Nephrolithiasis on topiramate therapy. , 2000, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[58] M. Daudon,et al. Crystalline phase differentiation in urinary calcium phosphate and magnesium phosphate calculi. , 1999, Scandinavian journal of urology and nephrology.
[59] D. Leusmann,et al. Potential contribution of optional urease-positive bacteria to idiopathic urinary calcium stone formation , 1996, Urological Research.
[60] M. Daudon,et al. Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[61] M. Daudon,et al. 2,8-dihydroxyadenine urolithiasis, an underdiagnosed disease , 1992, The Lancet.
[62] M. Daudon,et al. Urolithiasis in patients with end stage renal failure. , 1992, The Journal of urology.
[63] M. H. Gault,et al. Comparison of Patients with Idiopathic Calcium Phosphate and Calcium Oxalate Stones , 1991, Medicine.
[64] J. Lingeman,et al. The clinical implications of brushite calculi. , 1991, The Journal of urology.
[65] J. Lingeman,et al. Laxative abuse as a cause for ammonium urate renal calculi. , 1990, The Journal of urology.
[66] S. Dretler,et al. Cystine calculi--rough and smooth: a new clinical distinction. , 1989, The Journal of urology.
[67] M. Daudon,et al. Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis. , 1987, The Journal of urology.
[68] G. Preminger,et al. Nephrolithiasis from calcium supplementation. , 1987, The Journal of urology.
[69] M. Daudon,et al. PIRIDOXILATE-ASSOCIATED CALCIUM OXALATE URINARY CALCULI: A NEW METABOLIC DRUG-INDUCED NEPHROLITHIASIS , 1985, The Lancet.
[70] U. Liberman,et al. Hereditary hypophosphatemic rickets with hypercalciuria. , 1985, The New England journal of medicine.
[71] F. Coe,et al. Uric acid and calcium oxalate nephrolithiasis. , 1983, Kidney international.
[72] B. Kogan,et al. Renal calculi associated with incomplete distal renal tubular acidosis. , 1982, The Journal of urology.
[73] D. Griffith,et al. Infection-induced renal calculi. , 1982, Kidney international.
[74] M. Kass,et al. Acetazolamide and urolithiasis. , 1981, Ophthalmology.
[75] T. A. Taylor,et al. The endemic bladder stones of Indonesia---epidemiology and clinical features. , 1976, British journal of urology.
[76] R. Chalmers,et al. Metabolic investigations after xylitol infusion in human subjects. , 1976, The American journal of clinical nutrition.
[77] G. L. Gardner. Nucleation and crystal growth of calcium oxalate trihydrate , 1975 .
[78] L. Persky,et al. Calculus formation and ureteral colic following acetazolamide (diamox) therapy. , 1956, Journal of the American Medical Association.
[79] H. Tiselius,et al. Urolithiasis: Basic science and clinical practice , 2012 .
[80] J. Lingeman,et al. The role of Randall's plaques in the pathogenesis of calcium stones. , 2007, The Journal of urology.
[81] H. Tiselius,et al. Risk factors of calcium stone formation in patients with primary Sjögren's syndrome , 2004, Urological Research.
[82] C. P. Davis,et al. Intracellular crystal formation in bacteria from human urines: A contributing factor in urinary calculi , 2004, Urological Research.
[83] N. Piaseu,et al. Risk of Calcium Oxalate Nephrolithiasis after Calcium or Combined Calcium and Calcitriol Supplementation in Postmenopausal Women , 2000, Osteoporosis International.
[84] S. Scheinman. X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. , 1998, Kidney international.
[85] M. Daudon,et al. Contribution of Fourier transform infrared spectroscopy to the identification of urinary stones and kidney crystal deposits , 1997 .
[86] E. W. Czerwinski,et al. Calcium phosphate crystal formation in Escherichia coli from human urine: an in vitro study. , 1982, The Journal of urology.
[87] B. Pinto,et al. Isolation and characterization of uricine from uric acid stones. , 1976, Kidney international.